344 related articles for article (PubMed ID: 23512380)
21. Long-term results of breast reduction in female-to-male transsexuals.
Antoszewski B; Bratoś R; Sitek A; Fijałkowska M
Pol Przegl Chir; 2012 Mar; 84(3):144-51. PubMed ID: 22659357
[TBL] [Abstract][Full Text] [Related]
22. Transgender transitioning and change of self-reported sexual orientation.
Auer MK; Fuss J; Höhne N; Stalla GK; Sievers C
PLoS One; 2014; 9(10):e110016. PubMed ID: 25299675
[TBL] [Abstract][Full Text] [Related]
23. Quality of life of men and women with gender identity disorder.
Valashany BT; Janghorbani M
Health Qual Life Outcomes; 2018 Aug; 16(1):167. PubMed ID: 30126432
[TBL] [Abstract][Full Text] [Related]
24. Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF).
Fuss J; Hellweg R; Van Caenegem E; Briken P; Stalla GK; T'Sjoen G; Auer MK
Eur Neuropsychopharmacol; 2015 Jan; 25(1):95-9. PubMed ID: 25498415
[TBL] [Abstract][Full Text] [Related]
25. Sexual desire in female-to-male transsexual persons: exploration of the role of testosterone administration.
Wierckx K; Elaut E; Van Caenegem E; Van De Peer F; Dedecker D; Van Houdenhove E; T'Sjoen G
Eur J Endocrinol; 2011 Aug; 165(2):331-7. PubMed ID: 21602316
[TBL] [Abstract][Full Text] [Related]
26. Coordination of healthcare for transsexual persons: a multidisciplinary approach.
Esteva de Antonio I; Gómez-Gil E;
Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):585-91. PubMed ID: 24468763
[TBL] [Abstract][Full Text] [Related]
27. Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy.
Van Caenegem E; Wierckx K; Taes Y; Dedecker D; Van de Peer F; Toye K; Kaufman JM; T'Sjoen G
J Clin Endocrinol Metab; 2012 Jul; 97(7):2503-11. PubMed ID: 22564669
[TBL] [Abstract][Full Text] [Related]
28. Changing Demographics in Transgender Individuals Seeking Hormonal Therapy: Are Trans Women More Common Than Trans Men?
Leinung MC; Joseph J
Transgend Health; 2020 Dec; 5(4):241-245. PubMed ID: 33644314
[No Abstract] [Full Text] [Related]
29. Serum concentrations of brain-derived neurotrophic factor in patients diagnosed with gender dysphoria undergoing sex reassignment surgery.
Schneider MA; Andreazza T; Fontanari AM; Costa AB; Silva DC; Aguiar BW; Massuda R; Pedrini M; Gama CS; Schwarz K; Kauer-Sant'Anna M; Lobato MI
Trends Psychiatry Psychother; 2017; 39(1):43-47. PubMed ID: 28403322
[TBL] [Abstract][Full Text] [Related]
30. Differences in personality traits between male-to-female and female-to-male gender identity disorder subjects.
Miyajima E; Taira N; Koda M; Kondo T
Psychiatry Res; 2014 Dec; 220(1-2):496-9. PubMed ID: 25130781
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a transgender population in Portugal.
Ferreira MJ; Castedo JL; Mota M; Carvalho D
Ann Endocrinol (Paris); 2022 Feb; 83(1):35-39. PubMed ID: 34871600
[TBL] [Abstract][Full Text] [Related]
32. Psychosocial adjustment to sex reassignment surgery: a qualitative examination and personal experiences of six transsexual persons in croatia.
Jokić-Begić N; Lauri Korajlija A; Jurin T
ScientificWorldJournal; 2014; 2014():960745. PubMed ID: 24790589
[TBL] [Abstract][Full Text] [Related]
33. Translation, Cultural Adaptation, and Preliminary Evaluation of the Spanish Version of the Transgender Voice Questionnaire for Male-to-Female Transsexuals (TVQ
Mora E; Carrillo A; Giribet A; Becerra A; Lucio MJ; Cobeta I
J Voice; 2018 Jul; 32(4):514.e1-514.e6. PubMed ID: 28599997
[TBL] [Abstract][Full Text] [Related]
34. Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study.
Colizzi M; Costa R; Todarello O
Psychoneuroendocrinology; 2014 Jan; 39():65-73. PubMed ID: 24275005
[TBL] [Abstract][Full Text] [Related]
35. Clinical management of transsexual subjects.
Costa EM; Mendonca BB
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):188-96. PubMed ID: 24830596
[TBL] [Abstract][Full Text] [Related]
36. Female-to-Male Transsexual Individuals Demonstrate Different Own Body Identification.
Feusner JD; Dervisic J; Kosidou K; Dhejne C; Bookheimer S; Savic I
Arch Sex Behav; 2016 Apr; 45(3):525-36. PubMed ID: 26292839
[TBL] [Abstract][Full Text] [Related]
37. Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia.
Quirós C; Patrascioiu I; Mora M; Aranda GB; Hanzu FA; Gómez-Gil E; Godás T; Halperin I
Endocrinol Nutr; 2015 May; 62(5):210-6. PubMed ID: 25790747
[TBL] [Abstract][Full Text] [Related]
38. A novel method for estimating transgender status using electronic medical records.
Roblin D; Barzilay J; Tolsma D; Robinson B; Schild L; Cromwell L; Braun H; Nash R; Gerth J; Hunkeler E; Quinn VP; Tangpricha V; Goodman M
Ann Epidemiol; 2016 Mar; 26(3):198-203. PubMed ID: 26907539
[TBL] [Abstract][Full Text] [Related]
39. A Qualitative Study of the Acceptability of the Proposed ICD-11 Gender Incongruence of Childhood Diagnosis Among Transgender Adults Who Were Labeled Due to Their Gender Identity Since Childhood.
Vargas-Huicochea I; Robles R; Real T; Fresán A; Cruz-Islas J; Vega-Ramírez H; Medina-Mora ME
Arch Sex Behav; 2018 Nov; 47(8):2363-2374. PubMed ID: 29971651
[TBL] [Abstract][Full Text] [Related]
40. Sociodemographic profile of transsexual patients.
Duisin D; Nikolić-Balkoski G; Batinić B
Psychiatr Danub; 2009 Jun; 21(2):220-3. PubMed ID: 19556952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
